Improving blood transfusion monitoring in critical care patients: Insights from diffuse optics
Red blood cell transfusions (RBCTs) are life-saving treatments for critically ill patients suffering from anemia, a condition ...
The Hospitalist11h
As Wearable Monitors Proliferate, Hospitalists Weigh How to Use Them
The remote patient monitoring (RPM) technology that a patient uses while receiving hospital-at-home care does not follow a ...
Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade
Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period ...
pulmonologyadvisor14h
Continuous Glucose Monitoring Can Predict Microvascular Complications in Type 1 Diabetes
CGM traces added to DCCT data can predict microvascular diabetes complications similarly to glycated hemoglobin.
Dementia risk may be lowered by one important medical device
New research suggests that wearing continuous glucose monitors could lower the risk of dementia. Experts discuss how symptoms can overlap between diabetes and dementia.
Redburn raises DexCom stock rating to buy, price target to $115
DexCom (NASDAQ:DXCM) shares received an optimistic update from Redburn-Atlantic, with analyst Issie Kirby (NYSE:KEX) upgrading the stock from Neutral to Buy and increasing the price target to $115 ...